Overall, these results suggest that TRIM24-driven mouse metaplastic carcinosarcomas exhibit significant similarities to human MpBC tumors by gene expression and hallmark pathway profiling, offering an animal model of human triple-negative MpBC suitable for development of potential therapeutics. This evidence concerns the gene TRIM24 and carcinosarcoma.